Your browser doesn't support javascript.
loading
Trastuzumab-Resistant HER2+ Breast Cancer Cells Retain Sensitivity to Poly (ADP-Ribose) Polymerase (PARP) Inhibition.
Wielgos, Monica E; Zhang, Zhuo; Rajbhandari, Rajani; Cooper, Tiffiny S; Zeng, Ling; Forero, Andres; Esteva, Francisco J; Osborne, C Kent; Schiff, Rachel; LoBuglio, Albert F; Nozell, Susan E; Yang, Eddy S.
Afiliação
  • Wielgos ME; Department of Radiation Oncology, University of Alabama at Birmingham, Birmingham, Alabama.
  • Zhang Z; Department of Radiation Oncology, University of Alabama at Birmingham, Birmingham, Alabama.
  • Rajbhandari R; Department of Radiation Oncology, University of Alabama at Birmingham, Birmingham, Alabama.
  • Cooper TS; Department of Radiation Oncology, University of Alabama at Birmingham, Birmingham, Alabama.
  • Zeng L; Department of Radiation Oncology, University of Alabama at Birmingham, Birmingham, Alabama.
  • Forero A; Department of Medicine, University of Alabama at Birmingham, Birmingham, Alabama.
  • Esteva FJ; Breast Medical Oncology Program, NYU Cancer Institute, New York, New York.
  • Osborne CK; Lester and Sue Smith Breast Cancer, Baylor College of Medicine, Houston, Texas.
  • Schiff R; Dan L. Duncan Cancer Center, Baylor College of Medicine, Houston, Texas.
  • LoBuglio AF; Department of Medicine, Baylor College of Medicine, Houston, Texas.
  • Nozell SE; Department of Molecular and Cellular Biology, Baylor College of Medicine, Houston, Texas.
  • Yang ES; Lester and Sue Smith Breast Cancer, Baylor College of Medicine, Houston, Texas.
Mol Cancer Ther ; 17(5): 921-930, 2018 05.
Article em En | MEDLINE | ID: mdl-29592880
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias da Mama / Resistencia a Medicamentos Antineoplásicos / Ensaios Antitumorais Modelo de Xenoenxerto / Trastuzumab / Inibidores de Poli(ADP-Ribose) Polimerases Tipo de estudo: Diagnostic_studies / Prognostic_studies Limite: Animals / Female / Humans Idioma: En Revista: Mol Cancer Ther Assunto da revista: ANTINEOPLASICOS Ano de publicação: 2018 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias da Mama / Resistencia a Medicamentos Antineoplásicos / Ensaios Antitumorais Modelo de Xenoenxerto / Trastuzumab / Inibidores de Poli(ADP-Ribose) Polimerases Tipo de estudo: Diagnostic_studies / Prognostic_studies Limite: Animals / Female / Humans Idioma: En Revista: Mol Cancer Ther Assunto da revista: ANTINEOPLASICOS Ano de publicação: 2018 Tipo de documento: Article